Why is $ZBIO stock up today?
Zenas BioPharma, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS
Why is $ZBIO up today?
The likely driver
Zenas BioPharma Announces Data from the Registrational Phase 3 INDIGO Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD), Simultaneously Presented at the EULAR 2026 Congress and Published in the New England Journal of Medicine
GlobeNewswire Inc.·7:05 PM ETpositive
Price
$29.54
Move today
+0.1%
Volume vs avg
0.0x
Scanner alerts today
0
Other stocks moving today
Each opens that stock’s own why-is-it-moving page.
Move and volume are based on the latest market data and refresh live on this page. Scanner alerts are our own real-time unusual-volume signals. This is research, not investment advice.